Empa researchers are therefore working on sensors that quickly identify resistant germs and recommend efficient treatment. The spread of antibiotic-resistant superbugs is plunging health care ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
Mexican company Henkel Capital S.A. de C.V. recalled its contaminated Tec Italy shampoo that was distributed in New York and ...
Thomas A. Russo, MD, SUNY Distinguished Professor and chief of infectious diseases at the Jacobs School, is co-author on a Nature Communications paper analyzing hypervirulent pneumoniae infections.
GSK’s Blujepa receives US FDA nod to treat uncomplicated urinary tract infections in female and paediatric patients 12 years of age and older: Philadelphia Friday, March 28, 202 ...
The emergence of antibiotic-resistant strains threatens to set back the world a hundred years to the age when even a minor ...
Although this bacteria is considered healthy in your intestines, outside the gut, it can cause serious infections, ...
Interesting Engineering on MSN5d
New hope for UTI patients as FDA approves first-of-its-kind antibiotic in 30 yearsThe U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...
The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...
The US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene antibiotic, Blujepa (gepotidacin), for ...
The FDA has approved GSK’s gepotidacin, the first antibiotic for uncomplicated urinary tract infections in 30 years. The drug has been approved for female adults and adolescents with UTIs caused by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback